ICD-10-CM Alphabetic Index · FY 2026 91 Entries
Long-term drug therapy in the ICD-10-CM Index ICD-10-CM
The main term Long-term (current) (prophylactic) drug therapy (use of) carries 91 index entries pointing to 32 ICD-10-CM codes. Every indented line below refines the term by site, cause, or type. Verify any candidate code in the Tabular List before using it.
✓ Built from the official CMS FY 2026 index fileEffective Oct 1, 2025 – Sep 30, 2026
91
Index Entries
32
Codes Referenced
—
Default Code
L
Letter
91 of 91 shown
ICD-10-CM
Index Entries Under Long-term drug therapy 91 entries · 32 codes
Long-term (current) (prophylactic) drug therapy (use of)
5-fluorouracil Z79.631
6-mercaptopurine Z79.631
adalimumab Z79.620
agents affecting estrogen receptors and estrogen levels NEC Z79.818
alkylating agent Z79.630
anastrozole (Arimidex) Z79.811
antibiotics Z79.2
short-term use - omit code
anticoagulants Z79.01
antidiabetic drugs, injectable, non-insulin Z79.85
anti-inflammatory, non-steroidal (NSAID) Z79.1
antimetabolite agent Z79.631
antiplatelet Z79.02
antithrombotics Z79.02
antitumor antibiotic Z79.632
apremilast Z79.61
aromatase inhibitors Z79.811
aspirin Z79.82
azathioprine Z79.624
birth control pill or patch Z79.3
bisphosphonates Z79.83
bleomycin Z79.632
calcineurin inhibitor Z79.621
chlorambucil Z79.630
cisplatin Z79.630
contraceptive, oral Z79.3
cyclophosphamide Z79.630
cyclosporine Z79.621
cytarabine Z79.631
doxorubicin Z79.632
drug, specified NEC Z79.899
estrogen receptor downregulators Z79.818
etanercept Z79.620
etoposide Z79.634
Evista Z79.810
exemestane (Aromasin) Z79.811
Fareston Z79.810
fulvestrant (Faslodex) Z79.818
gonadotropin-releasing hormone (GnRH) agonist Z79.818
goserelin acetate (Zoladex) Z79.818
hormone replacement Z79.890
hydroxyurea Z79.64
immunomodulators, unspecified Z79.60
specified NEC Z79.69
immunomodulatory imide drug Z79.61
immunosuppressants, unspecified Z79.60
specified NEC Z79.69
immunosuppressive biologic Z79.620
infliximab Z79.620
inhibitors of nucleotide synthesis Z79.624
insulin Z79.4
irinotecan Z79.634
Janus kinase inhibitor Z79.622
lenalidomide Z79.61
letrozole (Femara) Z79.811
leuprolide acetate (leuprorelin) (Lupron) Z79.818
mammalian target of rapamycin (mTOR) inhibitor Z79.623
megestrol acetate (Megace) Z79.818
methadone for pain management Z79.891
mitomycin C Z79.632
mitotic inhibitor Z79.633
monoclonal antibodies Z79.620
mycophenolate Z79.624
myelosuppressive agent Z79.64
Nolvadex Z79.810
non-insulin antidiabetic drug, injectable Z79.85
non-steroidal anti-inflammatories (NSAID) Z79.1
opiate analgesic Z79.891
oral
antidiabetic Z79.84
contraceptive Z79.3
hypoglycemic Z79.84
paclitaxel Z79.633
plant alkaloids Z79.633
pomalidomide Z79.61
purine synthesis (IMDH) inhibitors Z79.624
raloxifene (Evista) Z79.810
selective estrogen receptor modulators (SERMs) Z79.810
sirolimus Z79.623
steroids
inhaled Z79.51
systemic Z79.52
tacrolimus Z79.621
tamoxifen (Nolvadex) Z79.810
tofacitinib Z79.622
topoisomerase inhibitor Z79.634
topotecan Z79.634
toremifene (Fareston) Z79.810
vinblastine Z79.633
vincristine Z79.633
The info icon previews the code's description and billable status; the code link opens its full page with all notations.
Related Index Terms
Source: Centers for Medicare & Medicaid Services, FY 2026 ICD-10-CM Index to Diseases and Injuries release files, effective October 1, 2025 through September 30, 2026.
